{
  "id": "adv_mhgap#risk_safety_bf1868f2",
  "content": "DEPENDENCE rarely, bullous skin reactions. CONTRAINDICATED in severe kidney disease\nand liver disease.\nNaltrexone Start 50 mg daily for 6-12 months. In opioid Sedation, dizziness, nausea/vomiting, abdominal Risk of FATAL OVERDOSE in patients who use\nTo suppress the urge to drink\ndependence, ensure that there has been no opioid pain, insomnia, anxiety, reduced energy, joint opioids more than 24 hours after their last dose of\nuse in the last 7 days (for example by administration and muscle pain. Monitor liver function due to naltrexone, due to the rapid loss of antagonistic effect.\nof dose of naloxone). risk of liver toxicity.\nDO NOT use in patients with liver failure or acute\nhepatitis.\nDisulfiram Start 200-400 mg daily. Drowsiness, dizziness, headache, flushing, Tricyclic antidepressants (TCAs), monamine oxidase\nsweating, dry mouth, nausea/vomiting, tremor, inhibitors (MAOIs), antipsychotics, vasodilators, and\nfoul body odour, sexual dysfunction. Rarely, alpha or beta adrenergic antagonists make the\npsychotic reactions, allergic dermatitis, disulfiram-alcohol reaction more serious. Sensitisation\nperipheral neuritis, or hepatic cell damage can to alcohol continues 6-14 days after taking disulfiram,\noccur. Severe reactions can lead to confusion, even if in small amounts.\ncardiovascular collapse, and death.\nDO NOT use with alcohol, as reactions can be\nlife-threatening or fatal.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "sleep",
      "study",
      "emotions",
      "risk_safety",
      "management"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General â€” Risk Safety DEPENDENCE rarely, bullous skin reactions. CONTRAINDICATED in severe kidney disease\nand liver disease.\nNaltrexone Start 50 mg daily for 6-12 months. In opioid Sedation, dizziness, nausea/vomiting, abdominal Risk of FATAL OVERDOSE in patients who use\nTo suppress the urge to drink\ndependence, ensure that there has been no opioid pain, insomnia, anxiety, reduced energy, joint opioids more than 24 hours after their last dose of\nuse in the last 7 days (for example by administration and muscle pain. Monitor liver function due to naltrexone, due to the rapid loss of antagonistic effect.\nof dose of naloxone). risk of liver toxicity.\nDO NOT use in patients with liver failure or acute\nhepatitis.\nDisulfiram Start 200-400 mg daily. Drowsiness, dizziness, headache, flushing, Tricyclic antidepressants (TCAs), monamine oxidase\nsweating, dry mouth, nausea/vomiting, tremor, inhibitors (MAOIs), antipsychotics, vasodilators, and\nfoul body odour, sexual dysfunction. Rarely, alpha or beta adrenergic antagonists make the\npsychotic reactions, allergic dermatitis, disulfiram-alcohol reaction more serious. Sensitisation\nperipheral neuritis, or hepatic cell damage can to alcohol continues 6-14 days after taking disulfiram,\noccur. Severe reactions can lead to confusion, even if in small amounts.\ncardiovascular collapse, and death.\nDO NOT use with alcohol, as reactions can be\nlife-threatening or fatal. Dependence rarely, bullous skin reactions. contraindicated in severe kidney disease\nand liver disease."
}